清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Management of 1- to 2-cm Carcinoid Tumors of the Appendix: Using the National Cancer Data Base to Address Controversies in General Surgery

普通外科 癌症 切除术
作者
Daniel P. Nussbaum,Paul J. Speicher,Brian C. Gulack,Jeffrey E. Keenan,Asvin M. Ganapathi,Brian R. Englum,Douglas S. Tyler,Dan G. Blazer
出处
期刊:Journal of The American College of Surgeons [Lippincott Williams & Wilkins]
卷期号:220 (5): 894-903 被引量:33
标识
DOI:10.1016/j.jamcollsurg.2015.01.005
摘要

Background The management of 1- to 2-cm appendiceal carcinoid tumors remains controversial. Here we use the National Cancer Data Base (NCDB) to compare long-term outcomes for patients treated via resection of the primary tumor alone vs right hemicolectomy (RHC). Study Design The 1998 to 2011 NCDB User File was queried to identify patients with 1- to 2-cm appendiceal carcinoids. Patients were stratified by surgical technique: resection of the primary tumor alone vs RHC with regional lymphadenectomy. Multivariable logistic regression was used to compare short-term outcomes. Survival was estimated using the Kaplan-Meier method with comparisons based on the log-rank test. Results A total of 916 patients were identified, including 42% managed with primary resection and 58% with RHC. Patients who underwent RHC had slightly larger tumors and higher-stage tumors; otherwise, there were no baseline differences between groups. The rates of positive margins were similar (5.5% vs 4.5%; p = 0.60). Among all patients, 1- and 5-year survival were 98.1% and 88.7% vs 96.7% and 87.4% (p = 0.52) for those managed via primary resection vs RHC, respectively. Among patients with moderate/high-grade/anaplastic carcinoids, 1- and 5-year survival were 93.3% and 72.0% vs 92.3% and 71.9%, respectively (p = 0.78). After adjustment with Cox proportional hazards modeling, we confirmed that there was no survival benefit for patients undergoing RHC (hazard ratio = 1.14; p = 0.72). Conclusions For 1- to 2-cm appendiceal carcinoids, formal resection of the right colon does not appear to improve survival, even for higher-grade tumors. Our findings suggest that resection of the primary tumor alone is adequate for all carcinoids

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小莫完成签到 ,获得积分10
刚刚
DDaylight完成签到,获得积分10
1秒前
末末完成签到 ,获得积分10
7秒前
闪闪的代秋完成签到 ,获得积分10
9秒前
solution完成签到 ,获得积分10
9秒前
笨笨完成签到 ,获得积分10
12秒前
was_3完成签到,获得积分0
25秒前
森诺完成签到 ,获得积分10
30秒前
DDaylight关注了科研通微信公众号
40秒前
科研人完成签到 ,获得积分10
49秒前
Yuyu完成签到 ,获得积分10
49秒前
蓝景轩辕完成签到 ,获得积分10
50秒前
wwe完成签到,获得积分10
55秒前
zhuosht完成签到 ,获得积分10
1分钟前
逢场作戱__完成签到 ,获得积分10
1分钟前
诺亚方舟哇哈哈完成签到 ,获得积分0
1分钟前
要减肥的冥完成签到,获得积分10
1分钟前
George完成签到,获得积分10
1分钟前
佳佳完成签到,获得积分10
1分钟前
byron完成签到 ,获得积分10
1分钟前
科目三应助阔达威采纳,获得10
1分钟前
yutingting完成签到,获得积分10
1分钟前
空儒完成签到 ,获得积分10
1分钟前
王佳亮完成签到,获得积分10
1分钟前
yuntong完成签到 ,获得积分0
2分钟前
无花果应助科研通管家采纳,获得10
2分钟前
2分钟前
ZHY2023发布了新的文献求助10
2分钟前
eth完成签到 ,获得积分10
2分钟前
2分钟前
阔达威发布了新的文献求助10
2分钟前
动人的诗霜完成签到 ,获得积分10
3分钟前
燕然都护发布了新的文献求助10
3分钟前
bkagyin应助阔达威采纳,获得10
3分钟前
cq_2完成签到,获得积分0
3分钟前
韩野完成签到,获得积分10
3分钟前
elisaw完成签到 ,获得积分10
3分钟前
lian完成签到 ,获得积分10
3分钟前
Turing完成签到,获得积分10
3分钟前
marvelou完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Research Methods for Applied Linguistics 500
Picture Books with Same-sex Parented Families Unintentional Censorship 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6413994
求助须知:如何正确求助?哪些是违规求助? 8232642
关于积分的说明 17476525
捐赠科研通 5466699
什么是DOI,文献DOI怎么找? 2888486
邀请新用户注册赠送积分活动 1865239
关于科研通互助平台的介绍 1703218